Turn Therapeutics TTRX Cash Flow Statement (2024-2026)

NASDAQ TTRX
$13.41 +0.37 (+2.84%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Turn Therapeutics Quarterly Cash Flow Statement

Periods 8 quarters
Latest Jun 2026

Turn Therapeutics reported cash from operations of -$0.97M and free cash flow of -$0.97M for the quarter ended Jun 2026, down 93.5% year over year. This cash flow statement covers 8 quarters of results from Sep 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -0.67M-0.32M-0.38M-1.37M-1.91M-2.18M-1.20M-1.63M
Share-based Compensation 0.04M0.08M0.05M0.04M0.26M0.28M0.42M
Cash from Operations -0.43M-0.30M-0.50M-0.59M-1.21M-1.63M-0.97M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.01M0.01M0.01M0.01M0.01M
Change in Working Capital
Change in Accured Expenses 0.05M-0.02M0.37M1.25M0.66M-0.61M0.29M
Other Working Capital Changes 0.22M0.29M-0.31M-0.02M-0.07M0.12M-0.10M
Investing Activities
Change in Intangibles 0.01M0.09M0.03M0.01M0.01M
Cash from Investing Activities -0.01M-0.09M-0.03M-0.01M-0.01M
Financing Activities
Change in Capital Stock
Net Equity Issued and Repurchased 0.52M1.00M2.15M0.59M3.18M
Misc.
Cash from Financing Activities 0.52M1.00M2.15M0.59M3.18M7.79M1.00
Change in Cash 0.08M0.70M1.62M-0.08M1.97M6.14M-0.93M
Free Cash Flow -0.43M-0.30M-0.50M-0.59M-1.21M-1.63M-0.97M
Net Cash Flow 0.08M0.70M1.65M-0.09M1.94M6.14M-0.97M

Turn Therapeutics Cash Flow Statement API

Pull Turn Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TTRX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY